Total Payments
$13,905
2024 Payments
$3,194
Companies
59
Transactions
632
Medicare Patients
3,077
Medicare Billing
$458,417
Payment Breakdown by Category
Food & Beverage$13,461 (96.8%)
Education$444.19 (3.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,461 | 624 | 96.8% |
| Education | $444.19 | 8 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,743 | 88 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,487 | 185 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $875.58 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $838.73 | 45 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $813.00 | 24 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $618.20 | 32 | $0 (2024) |
| GENZYME CORPORATION | $462.89 | 22 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $462.03 | 22 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $368.81 | 23 | $0 (2020) |
| Mylan Specialty L.P. | $340.06 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,194 | 145 | AstraZeneca Pharmaceuticals LP ($931.94) |
| 2023 | $2,990 | 112 | AstraZeneca Pharmaceuticals LP ($686.91) |
| 2022 | $1,241 | 68 | AstraZeneca Pharmaceuticals LP ($263.23) |
| 2021 | $489.88 | 30 | GlaxoSmithKline, LLC. ($133.44) |
| 2020 | $1,170 | 60 | GlaxoSmithKline, LLC. ($428.94) |
| 2019 | $1,401 | 68 | GlaxoSmithKline, LLC. ($327.80) |
| 2018 | $1,909 | 72 | GlaxoSmithKline, LLC. ($324.63) |
| 2017 | $1,510 | 77 | AstraZeneca Pharmaceuticals LP ($220.04) |
All Payment Transactions
632 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Immunology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $127.06 | General |
| Category: PULMONOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), ZERBAXA, DIFICID | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Immunology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Immunology | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Hyperkalemia | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 769 | 1,131 | $369,125 | $107,718 |
| 2022 | 15 | 789 | 1,385 | $385,692 | $124,521 |
| 2021 | 15 | 767 | 1,281 | $362,081 | $120,637 |
| 2020 | 16 | 752 | 1,244 | $231,045 | $105,540 |
Total Patients
3,077
Total Services
5,041
Medicare Billing
$458,417
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 95 | 215 | $118,250 | $36,027 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 148 | 331 | $57,610 | $20,608 | 35.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 100 | $25,000 | $9,272 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 106 | $25,440 | $9,059 | 35.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $16,100 | $6,506 | 40.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 45 | $11,250 | $4,604 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 57 | $9,120 | $3,520 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 25 | $8,250 | $3,476 | 42.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 32 | 32 | $48,590 | $3,065 | 6.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $7,400 | $2,656 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,440 | $2,649 | 35.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 17 | 17 | $11,925 | $1,478 | 12.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $2,850 | $1,137 | 39.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 15 | 16 | $3,420 | $678.24 | 19.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 24 | 24 | $3,960 | $619.10 | 15.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 16 | 17 | $2,295 | $559.30 | 24.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 19 | $880.00 | $557.84 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $825.00 | $528.48 | 64.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 15 | 15 | $7,500 | $515.10 | 6.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 12 | $1,020 | $203.00 | 19.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 93 | 228 | $125,400 | $39,483 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 203 | 558 | $74,115 | $31,323 | 42.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 108 | 110 | $40,700 | $16,896 | 41.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 80 | 149 | $29,450 | $11,748 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 131 | $31,440 | $11,383 | 36.2% |
About Dr. Ritha Kartan, MD
Dr. Ritha Kartan, MD is a Critical Care Medicine healthcare provider based in Boardman, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760452304.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ritha Kartan, MD has received a total of $13,905 in payments from pharmaceutical and medical device companies, with $3,194 received in 2024. These payments were reported across 632 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($13,461).
As a Medicare-enrolled provider, Kartan has provided services to 3,077 Medicare beneficiaries, totaling 5,041 services with total Medicare billing of $458,417. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Boardman, OH
- Active Since 01/25/2006
- Last Updated 11/07/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760452304
Products in Payments
- DUPIXENT (Biological) $1,052
- TEZSPIRE (Biological) $851.45
- NUCALA (Biological) $835.67
- TRELEGY ELLIPTA (Drug) $762.95
- AIRSUPRA (Drug) $633.31
- XYWAV (Drug) $472.21
- WAKIX (Drug) $357.63
- AREXVY (Drug) $341.12
- Xyrem (Drug) $323.12
- OFEV (Drug) $313.83
- FASENRA (Biological) $312.40
- BEVESPI AEROSPHERE (Drug) $255.99
- SYMBICORT (Drug) $228.38
- STIOLTO RESPIMAT (Drug) $223.40
- BREZTRI (Drug) $204.80
- Prolastin-C Liquid (Biological) $188.28
- ANORO (Drug) $174.81
- ACTHAR (Biological) $174.28
- XOLAIR (Biological) $173.60
- Yupelri (Drug) $173.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.